Page 87 - Summer2015
P. 87

Soy Alert!


                    SOY AND ASTHMA: MORE BAD NEWS FOR THE SOY INDUSTRY

                                            By Kaayla T. Daniel, PhD, CCN






              Soy does not help people suffering from     Could soy come to the rescue? Lewis J.
          asthma. That was the conclusion of a study  Smith MD, of the Department of Medicine at
          published in the May 26 issue of Journal of the  Northwestern University, and colleagues hoped
          American Medical Association (JAMA). The re-  so. They thought the soy estrogens known as iso-
          searchers said they were “disappointed” because  flavones would help adolescent and adult patients
          they had hoped that soy would prove to be a safe,  suffering from poorly controlled asthma because
          non-toxic and inexpensive alternative to asthma  asthma rates are lower in Asia where they as-
          medications.                              sumed that people consume massive amounts of
              According to the Environmental Protec-  soy. (In fact, in most of Asia, soy is consumed
          tion Agency (EPA), 25.9 million Americans,  in small quantities as a condiment in the diet
          including one in eight children and one in twelve  and not as a staple food.) The researchers were   The
          adults, suffer from asthma, at an economic cost  also inspired by in vitro studies that showed soy   researchers
          of at least fifty-six billion dollars per year in  genistein can reduce eosinophil inflammation,
          direct costs for hospital visits, doctors and drugs  an important factor in asthma. As quoted in Sci-  said they were
          and in indirect costs from lost school and work  ence Daily, Dr. Smith said, “There was enough   “disappointed”
          days. Experts say they do not know why asthma  epidemiological and biological evidence data to   because they
          rates have been steadily increasing over the past  support looking at this association.”
          twenty years; most think the best that can be done     Smith and his team carried out the random-  had hoped
          is to educate people and medicate symptoms.  ized, double-blind, placebo-controlled clinical   that soy would
          As Thomas R. Frieden, MD, MPH, Director of  trial between May 2010 and August 2012 at   prove to be
          the Centers for Disease Control (CDC), put it,  nineteen adult and pediatric pulmonary and al-
          “Asthma is a serious, lifelong disease that unfor-  lergy centers in the American Lung Association   a safe,
          tunately kills thousands of people each year and  Asthma Clinical Research Center's network.   non-toxic and
          adds billions to our nation's health care costs. We  They randomly assigned one hundred ninety-  inexpensive
          have to do a better job educating people about  three patients to receive a soy isoflavone supple-
          managing their symptoms and how to correctly  ment containing 100 mg of total isoflavones and   alternative
          use medicines to control asthma so they can live  one hundred ninety-three patients to receive a   to asthma
          longer, more productive lives while saving health  placebo, and did blood tests to prove the subjects   medications.
          care costs.”

                                                UPDATES ON SOY LITIGATION

           SOY PRISON LAWSUIT: On February 25, 2015, Judge Baker of the United States District Court for the central district of
           Illinois cited conflicting scientific evidence when he dismissed the claim of Harris and others that the feeding of too much
           soy constituted a violation of their Eighth Amendment constitutional rights. With the backing of the Weston A. Price Foun-
           dation, Harris and the other plaintiffs will appeal to the Seventh Circuit United States Court of Appeals, located in Chicago.

           SOY LABELING PETITION: In 2008, WAPF sent a citizen petition to the FDA urging regulators to withdraw the claim that
           soy could prevent heart disease. After more than six years and no response from FDA, WAPF is suing the agency to address
           the petition. After meetings with FDA officials and James Turner, Esq, the Foundation's general counsel, the FDA promised
           a reply within six months.
 Wise Traditions   SUMMER 2015                       Wise Traditions                                           87





   154242_V16N2_text.indd   87                                                                                 6/25/15   3:55 PM
   82   83   84   85   86   87   88   89   90   91   92